(Q82976014)

English

Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantation

scientific article published on 01 May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

5

object named as

Neil E Kay

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Robert A Kyle

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Traci Leong

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Shuli Li

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Martin M Oken

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Brian Van Ness

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Philip R Greipp

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 May 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

106

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1958-1966

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Combination chemotherapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Medical Research Council Working Party for Leukaemia in Adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic Factors in Autologous Stem Cell Transplantation for Multiple Myeloma: An EBMT Registry Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of complete remission with intensive therapy in patients with responsive multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of complete response on outcome following autologous stem cell transplantation for myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21804

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21804

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82976014&oldid=1750611566"